Legend Biotech Corporation American Depositary Shares

14 analysts have shared their evaluations of Legend Biotech (NASDAQ:LEGN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 8 6 0 0 0 Last 30D 1 0 0 0 0 1M Ago 3 1 0 0 0 2M Ago 3 1 0 0 0 3M Ago 1 4 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $84.07, a high estimate of $87.00, and a low estimate of $65.00. Observing a 10.62% increase, the current average has risen from the previous average price target of $76.00. Investigating Analyst Ratings: An Elaborate Study A clear picture of Legend Biotech's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Mitchell Kapoor HC Wainwright & Co. Lowers Buy $86.00 $87.00 Mitchell Kapoor HC Wainwright & Co. Maintains Buy $87.00 - Mitchell Kapoor HC Wainwright & Co. Maintains Buy $87.00 - George Farmer Scotiabank Maintains Sector Outperform $65.00 $65.00 Mitchell Kapoor HC Wainwright & Co. Maintains Buy $87.00 - Rick Bienkowski Cantor Fitzgerald Announces Overweight $82.00 - Mitchell Kapoor HC Wainwright & Co. Maintains Buy $87.00 - Ashwani Verma UBS Raises Buy $81.00 $76.00 Mitchell Kapoor HC Wainwright & Co. Maintains Buy $87.00 - Mitchell Kapoor HC Wainwright & Co. Maintains Buy $87.00 - Sean McCutcheon Raymond James Announces Outperform $86.00 - Leonid Timashev RBC Capital Maintains Outperform $85.00 - Leonid Timashev RBC Capital Maintains Outperform $85.00 - Leonid Timashev RBC Capital Maintains Outperform $85.00 - Key Insights: Action Taken: Analysts adapt ...Full story available on Benzinga.com

Related tickers: LEGN.

Legend Biotech (LEGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Related tickers: LEGN.